The potential effect of metallothionein 2A -5 A/G single nucleotide polymorphism on blood cadmium, lead, zinc and copper levels

Toxicology and Applied Pharmacology

Volumn 256, Issue 1, 2011, Pages 1-7

  Kayaalti, Zeliha ^a   Aliyev, Vugar ^a   Söylemezoǧlu, Tülin ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

AAS; Core promoter region; Metal levels; Metallothionein 2A polymorphism; PCR RFLP

Indexed keywords

CADMIUM; COPPER; HEAVY METAL; LEAD; METALLOTHIONEIN II; ZINC;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD SAMPLING; COPPER BLOOD LEVEL; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; LEAD BLOOD LEVEL; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; ZINC BLOOD LEVEL;

ADENINE NUCLEOTIDES; ADOLESCENT; ADULT; AGED; CADMIUM; COPPER; FEMALE; GENETIC MARKERS; GENOTYPE; GUANINE NUCLEOTIDES; HUMANS; LEAD; MALE; METALLOTHIONEIN; METALS, HEAVY; MIDDLE AGED; POISONING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; YOUNG ADULT; ZINC;

EID: 80052314667     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.06.023     Document Type: Article

References (49)

1. Al-Saleh I., Shinwari N., Mashhour A., Mohamed Gel D., Rabah A. Heavy metals (lead, cadmium and mercury) in maternal, cord blood and placenta of healthy women. Int. J. Hyg. Environ. Health 2011, 214:79-101.
2. Amiard J.C., Amiard-Triquet C., Barka S., Pelerin J., Rainbow P.S. Metallothioneins in aquatic invertebrates: their role in metal detoxification and their use as biomarkers. Aquat. Toxicol. 2006, 76:160-202.
3. Barbosa F., Tanus-Santos J.E., Gerlach R.F., Parsons P.J. A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ. Health Perspect. 2005, 113:1669-1674.
4. Bremner I. Manifestations of copper excess. Am. J. Clin. Nutr. 1998, 67:1069S-1073S.
5. Brüwer M., Schmid K.W., Metz K.A., Krieglstein C.F., Senninger N., Schürmann G. Increased expression of metallothionein in inflammatory bowel disease. Inflamm. Res. 2001, 50:289-293.
6. Chan H.M., Cherian M.G. Mobilization of hepatic cadmium in pregnant rats. Toxicol. Appl. Pharmacol. 1993, 120:308-314.
7. Chen L., Jin T., Huang B., Chang X., Lei L., Nordberg G.F., Nordberg M. Plasma metallothionein antibody and cadmium-induced renal dysfunction in an occupational population in China. Toxicol. Sci. 2006, 91:104-112.
8. Cherian M.G. The significance of the nuclear and cytoplasmic localization of metallothionein in human liver and tumor cells. Environ. Health Perspect. 1994, 102:131-135.
9. Cherian M.G., Kang Y.J. Metallothionein and liver cell regeneration. Exp. Biol. Med. 2006, 231:138-144.
10. Dabrio M., Rodríguez A.R., Bordin G., Bebianno M.J., De Ley M., Sestáková I., Vasák M., Nordberg M. Recent developments in quantification methods for metallothionein. J. Inorg. Biochem. 2002, 88:123-134.
11. Ebert M.P., Günther T., Hoffmann J., Yu J., Miehlke S., Schulz H.U., Roessner A., Korc M., Malfertheiner P. Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer. Cancer Res. 2000, 60:1995-2001.
12. Garrick M.D., Singleton S.T., Vargas F., Kuo H.C., Zhao L., Knöpfel M., Davidson T., Costa M., Paradkar P., Roth J.A., Garrick L.M. DMT1: which metals does it transport?. Biol. Res. 2006, 39:79-85.
13. Giacconi R., Cipriano C., Muti E., Costarelli L., Maurizio C., Saba V., Gasparini N., Malavolta M., Mocchegiani E. Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology 2005, 6:407-413.
14. Goering P.L., Klaassen C.D. Tolerance to cadmium-induced toxicity depends on presynthesized metallothionein in liver. J. Toxicol. Environ. Health 1984, 14:803-812.
15. Gundacker C., Wittmann K.J., Kukuckova M., Komarnicki G., Hikkel I., Gencik M. Genetic background of lead and mercury metabolism in a group of medical students in Austria. Environ. Res. 2009, 109:786-796.
16. Hayashi Y., Hashizume T., Wakida K., Satoh M., Uchida Y., Watabe K., Matsuyama Z., Kimura A., Inuzuka T., Hozumi I. Association between metallothionein genes polymorphisms and sporadic amyotrophic lateral sclerosis in a Japanese population. Amyotroph. Lateral Scler. 2006, 7:22-26.
17. Hu H. Bone lead as a new biologic marker of lead dose: recent findings and implications for public health. Environ. Health Perspect. 1998, 106:961-967.
18. Ikebuchi H., Teshima R., Suzuki K., Terao T., Yamane Y. Stimultaneous induction of Pb-metallothionein-like protein and Zn-thionein in the liver of rats given lead acetate. Biochem. J. 1986, 223:541-546.
19. Jacob C., Maret W., Vallee B.L. Control of zinc transfer between thionein, metallothionein, and zinc proteins. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:3489-3494.
20. Järup L. Hazards of heavy metal contamination. Br. Med. Bull. 2003, 68:167-182.
21. Järup L., Akesson A. Current status of cadmium as an environmental health problem. Toxicol. Appl. Pharmacol. 2009, 238:201-208.
22. Kayaalti Z., Söylemezoǧlu T. The polymorphism of core promoter region on metallothionein 2A-metal binding protein in Turkish population. Mol. Biol. Rep. 2010, 37:185-190.
23. Kayaalti Z., Mergen G., Söylemezoǧlu T. Effect of metallothionein core promoter region polymorphism on cadmium, zinc and copper levels in autopsy kidney tissues from a Turkish population. Toxicol. Appl. Pharmacol. 2010, 245:252-255.
24. Kayaalti Z., Sahiner L., Durakoǧlugil M.E., Söylemezoǧlu T. Distributions of interleukin-6 (IL-6) promoter and metallothionein 2A (MT2A) core promoter region gene polymorphisms and their associations with aging in Turkish population. Arch. Gerontol. Geriatr. 2011, 53:354-358.
25. Kelly E.J., Quaife C.J., Froelick G.J., Palmiter R.D. Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice. J. Nutr. 1996, 126:1782-1790.
26. Kita K., Miura N., Yoshida M., Yamazaki K., Ohkubo T., Imai Y., Naganuma A. Potential effect on cellular response to cadmium of a single-nucleotide A ->G polymorphism in the promoter of the human gene for metallothionein IIA. Hum. Genet. 2006, 120:553-560.
27. Koizumi S., Suzuki K., Ogra Y., Yamada H., Otsuka F. Transcriptional activity and regulatory protein binding of metal-responsive elements of the human metallothionein-IIA gene. Eur. J. Biochem. 1999, 259:635-642.
28. Landrigan P.J., Boffetta P., Apostoli P. The reproductive toxicity and carcinogenicity of lead: a critical review. Am. J. Ind. Med. 2000, 38:231-243.
29. Liu Y., Liu J., Habeebu S.M., Waalkes M.P., Klaassen C.D. Metallothionein-I/II null mice are sensitive to chronic oral cadmium-induced nephrotoxicity. Toxicol. Sci. 2000, 57:167-176.
30. McElroy J.A., Bryda E.C., McKay S.D., Schnabel R.D., Taylor J.F. Genetic variation at a metallothionein 2A promoter single-nucleotide polymorphism in white and black females in Midwestern United States. J. Toxicol. Environ. Health A 2010, 73:1283-1287.
31. Memon A.R., Kazi T.G., Afridi H.I., Jamali M.K., Arain M.B., Jalbani N., Syed N. Evaluation of zinc status in whole blood and scalp hair of female cancer patients. Clin. Chim. Acta 2007, 379:66-70.
32. Miles A.T., Hawksworth G.M., Beattie J.H., Rodilla V. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit. Rev. Biochem. Mol. Biol. 2000, 35:35-70.
33. Moffatt P., Séguin C. Expression of the gene encoding metallothionein-3 in organs of the reproductive system. DNA Cell Biol. 1998, 17:501-510.
34. Nartey N.O., Banerjee D., Cherian M.G. Immunohistochemical localization of metallothionein in cell nucleus and cytoplasm of fetal human liver and kidney and its changes during development. Pathology 1987, 19:233-238.
35. Nilsson U., Attewell R., Christoffersson J.-O., Schutz A., Ahlgren L., Skerfving S., Mattsson S. Kinetics of lead in bone and bfood after end of occupational exposure. Pharmacol. Toxicol. 1991, 69:477-484.
36. Nordberg M. Metallothioneins: historical review and state of knowledge. Talanta 1998, 46:243-254.
37. Pan J., Plant J.A., Voulvoulis N., Oates C.J., Ihlenfeld C. Cadmium levels in Europe: implications for human health. Environ. Geochem. Health 2010, 32:1-12.
38. Qu W., Diwan B.A., Liu J., Goyer R.A., Dawson T., Horton J.L., Cherian M.G., Waalkes M.P. The metallothionein-null phenotype is associated with heightened sensitivity to lead toxicity and an inability to form inclusion bodies. Am. J. Pathol. 2002, 160:1047-1056.
39. Quaife C.J., Findley S.D., Erickson J.C., Froelick G.J., Kelly E.J., Zambrowicz B.P., Palmiter R.D. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 1994, 33:7250-7259.
40. Rana S.V. Metals and apoptosis: recent developments. J. Trace Elem. Med. Biol. 2008, 22:262-284.
41. Robert F., Forget D., Li J., Greenblatt J., Coulombe B. Localization of subunits of transcription factors IIE and IIF immediately upstream of the transcriptional initiation site of the adenovirus major late promoter. J. Biol. Chem. 1996, 271:8517-8520.
42. Samson S.L., Gedamu L. Molecular analyses of metallothionein gene regulation. Prog. Nucleic Acid Res. Mol. Biol. 1998, 59:257-288.
43. Silbergeld E.K., Weaver V.M. Exposure to metals: are we protecting the workers?. Occup. Environ. Med. 2007, 64:141-142.
44. Suzuki K., Koizumi S. Individual metal responsive elements of the metallothionein-IIA gene independently mediate responses to various heavy metal signals. Ind. Health 2000, 38:87-90.
45. Tekin D., Kayaalti Z., Aliyev V., Söylemezoǧlu T. The effects of metallothionein 2A polymorphism on placental cadmium accumulation: is metallothionein a modifiying factor in transfer of micronutrients to the fetus?. J. Appl. Toxicol. 2011, [Epub ahead of print]. 10.1002/jat.1661.
46. Vasak M. Advances in metallothionein structure and functions. J. Trace Elem. Med. Biol. 2005, 19:13-17.
47. Waalkes M.P., Harvey M.J., Klaassen C.D. Relative in vitro affinity of hepatic metallothionein for metals. Toxicol. Lett. 1984, 20:33-39.
48. Waalkes M.P., Liu J., Goyer R.A., Diwan B.A. Metallothionein-I/II double knockout mice are hypersensitive to lead-induced kidney carcinogenesis: role of inclusion body formation. Cancer Res. 2004, 64:7766-7772.
49. Yoshida M., Ohta H., Yamauchi Y., Seki Y., Sagi M., Yamazaki K., Sumi Y. Age-dependent changes in metallothionein levels in liver and kidney of the Japanese. Biol. Trace Elem. Res. 1998, 63:167-175.